Flunitrazepam increases the risk of lamotrigine‐induced cutaneous adverse reactions: Combined analysis of medical big data and clinical research
Sign Up to like & getrecommendations! Published in 2025 at "Psychiatry and Clinical Neurosciences"
DOI: 10.1111/pcn.13866
Abstract: The concomitant use of lamotrigine and valproic acid, a uridine diphosphate (UDP)‐glucuronosyltransferase inhibitor, is a known risk factor for lamotrigine‐induced rashes, which may develop into fatal or severe cutaneous adverse reactions. No drugs other than… read more here.
Keywords: adverse reactions; cutaneous adverse; lamotrigine; risk lamotrigine ... See more keywords